201 related articles for article (PubMed ID: 24330824)
1. Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcoma.
Yang J; Zhao L; Tian W; Liao Z; Zheng H; Wang G; Chen K
BMC Med Genomics; 2013 Dec; 6():56. PubMed ID: 24330824
[TBL] [Abstract][Full Text] [Related]
2. Frequent attenuation of the WWOX tumor suppressor in osteosarcoma is associated with increased tumorigenicity and aberrant RUNX2 expression.
Kurek KC; Del Mare S; Salah Z; Abdeen S; Sadiq H; Lee SH; Gaudio E; Zanesi N; Jones KB; DeYoung B; Amir G; Gebhardt M; Warman M; Stein GS; Stein JL; Lian JB; Aqeilan RI
Cancer Res; 2010 Jul; 70(13):5577-86. PubMed ID: 20530675
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the WWOX gene and frequent loss of its protein expression in human osteosarcoma.
Yang J; Cogdell D; Yang D; Hu L; Li H; Zheng H; Du X; Pang Y; Trent J; Chen K; Zhang W
Cancer Lett; 2010 May; 291(1):31-8. PubMed ID: 19896763
[TBL] [Abstract][Full Text] [Related]
4. Deregulated WWOX is involved in a negative feedback loop with microRNA-214-3p in osteosarcoma.
Gao K; Yin J; Dong J
Int J Mol Med; 2016 Dec; 38(6):1850-1856. PubMed ID: 27840941
[TBL] [Abstract][Full Text] [Related]
5. Genetic amplification of the vascular endothelial growth factor (VEGF) pathway genes, including VEGFA, in human osteosarcoma.
Yang J; Yang D; Sun Y; Sun B; Wang G; Trent JC; Araujo DM; Chen K; Zhang W
Cancer; 2011 Nov; 117(21):4925-38. PubMed ID: 21495021
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-34c inversely couples the biological functions of the runt-related transcription factor RUNX2 and the tumor suppressor p53 in osteosarcoma.
van der Deen M; Taipaleenmäki H; Zhang Y; Teplyuk NM; Gupta A; Cinghu S; Shogren K; Maran A; Yaszemski MJ; Ling L; Cool SM; Leong DT; Dierkes C; Zustin J; Salto-Tellez M; Ito Y; Bae SC; Zielenska M; Squire JA; Lian JB; Stein JL; Zambetti GP; Jones SN; Galindo M; Hesse E; Stein GS; van Wijnen AJ
J Biol Chem; 2013 Jul; 288(29):21307-21319. PubMed ID: 23720736
[TBL] [Abstract][Full Text] [Related]
7. Characterization of canine osteosarcoma by array comparative genomic hybridization and RT-qPCR: signatures of genomic imbalance in canine osteosarcoma parallel the human counterpart.
Angstadt AY; Motsinger-Reif A; Thomas R; Kisseberth WC; Guillermo Couto C; Duval DL; Nielsen DM; Modiano JF; Breen M
Genes Chromosomes Cancer; 2011 Nov; 50(11):859-74. PubMed ID: 21837709
[TBL] [Abstract][Full Text] [Related]
8. RUNX2 (6p21.1) amplification in osteosarcoma.
Gupta S; Ito T; Alex D; Vanderbilt CM; Chang JC; Islamdoust N; Zhang Y; Nafa K; Healey J; Ladanyi M; Hameed MR
Hum Pathol; 2019 Dec; 94():23-28. PubMed ID: 31669178
[TBL] [Abstract][Full Text] [Related]
9. WWOX inhibits the invasion of lung cancer cells by downregulating RUNX2.
Zheng QW; Zhou YL; You QJ; Shou F; Pang QF; Chen JL
Cancer Gene Ther; 2016 Dec; 23(12):433-438. PubMed ID: 27834355
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-205 acts as a tumor suppressor in osteosarcoma via targeting RUNX2.
Zhang C; Long F; Wan J; Hu Y; He H
Oncol Rep; 2016 Jun; 35(6):3275-84. PubMed ID: 27035764
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-338-3p inhibits tumor growth and metastasis in osteosarcoma cells by targeting RUNX2/CDK4 and inhibition of MAPK pathway.
Jia F; Zhang Z; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6420-6430. PubMed ID: 30484892
[TBL] [Abstract][Full Text] [Related]
12. The genetic basis for inactivation of Wnt pathway in human osteosarcoma.
Du X; Yang J; Yang D; Tian W; Zhu Z
BMC Cancer; 2014 Jun; 14():450. PubMed ID: 24942472
[TBL] [Abstract][Full Text] [Related]
13. High Coexpression of Runt-related Transcription Factor 2 (RUNX2) and p53 Independently Predicts Early Tumor Recurrence in Bladder Urothelial Carcinoma Patients.
Abdelzaher E; Kotb AF
Appl Immunohistochem Mol Morphol; 2016; 24(5):345-54. PubMed ID: 25906126
[TBL] [Abstract][Full Text] [Related]
14. Evidence of molecular alterations in the tumour suppressor gene WWOX in benign and malignant bone related lesions of the jaws.
Diniz MG; Borges ER; Pimenta FJ; De Mesquita Netto AC; De Marco L; Gomez RS; Gomes CC
Oncol Rep; 2011 Feb; 25(2):499-502. PubMed ID: 21165567
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional regulation of Runx2 by HSP90 controls osteosarcoma apoptosis via the AKT/GSK-3β/β-catenin signaling.
Liang GH; Liu N; He MT; Yang J; Liang ZJ; Gao XJ; Rahhal AH; He QY; Zhang HT; Zha ZG
J Cell Biochem; 2018 Jan; 119(1):948-959. PubMed ID: 28681940
[TBL] [Abstract][Full Text] [Related]
16. WWOX and p53 Dysregulation Synergize to Drive the Development of Osteosarcoma.
Del Mare S; Husanie H; Iancu O; Abu-Odeh M; Evangelou K; Lovat F; Volinia S; Gordon J; Amir G; Stein J; Stein GS; Croce CM; Gorgoulis V; Lian JB; Aqeilan RI
Cancer Res; 2016 Oct; 76(20):6107-6117. PubMed ID: 27550453
[TBL] [Abstract][Full Text] [Related]
17. Wnt/β-Catenin Signaling Activates Expression of the Bone-Related Transcription Factor RUNX2 in Select Human Osteosarcoma Cell Types.
Vega OA; Lucero CMJ; Araya HF; Jerez S; Tapia JC; Antonelli M; Salazar-Onfray F; Las Heras F; Thaler R; Riester SM; Stein GS; van Wijnen AJ; Galindo MA
J Cell Biochem; 2017 Nov; 118(11):3662-3674. PubMed ID: 28370561
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.
Li C; Zhang S; Qiu T; Wang Y; Ricketts DM; Qi C
Cancer Biol Ther; 2019; 20(4):413-422. PubMed ID: 30489194
[TBL] [Abstract][Full Text] [Related]
19. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells.
Niu J; Sun Y; Guo Q; Niu D; Liu B
Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493
[TBL] [Abstract][Full Text] [Related]
20. Genomic promoter occupancy of runt-related transcription factor RUNX2 in Osteosarcoma cells identifies genes involved in cell adhesion and motility.
van der Deen M; Akech J; Lapointe D; Gupta S; Young DW; Montecino MA; Galindo M; Lian JB; Stein JL; Stein GS; van Wijnen AJ
J Biol Chem; 2012 Feb; 287(7):4503-17. PubMed ID: 22158627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]